N,N',N'-Trimethylurea → HCID 71252090, compound
Reaction equation
[CH3:1][C:2]1[C:3]([N:9]2[CH2:14][CH2:13][N:12]([C:15]([C:17]3[CH:22]=[CH:21][C:20](I)=[CH:19][CH:18]=3)=[O:16])[CH2:11][CH2:10]2)=[N:4][CH:5]=[C:6]([CH3:8])[CH:7]=1.[CH3:24][NH:25][C:26](=[O:30])[N:27]([CH3:29])[CH3:28]>>[CH3:1][C:2]1[C:3]([N:9]2[CH2:14][CH2:13][N:12]([C:15]([C:17]3[CH:22]=[CH:21][C:20]([N:25]([CH3:24])[C:26]([N:27]([CH3:29])[CH3:28])=[O:30])=[CH:19][CH:18]=3)=[O:16])[CH2:11][CH2:10]2)=[N:4][CH:5]=[C:6]([CH3:8])[CH:7]=1Participants
3
Procedure
Using [4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl](4-iodophenyl)methanone (211 mg) described in Preparation Example 113 and trimethylurea (77 mg) and by the reaction and treatment in the same manner as in Example 262, the title compound (127 mg) was obtained.
Sources & evidence
- ORD record
- ord-c17e6a3260424096b7b51705df9ea77b
- Source dataset
- uspto-grants-2014_08
- Patent number
- US08816079B2
Reaction notes
Loading…